01 / APPLICATION
Asthma
A platform in development for maintenance inhalation therapy.
The project considers the inspiratory effort required by conventional dry powder inhalers and the coordination required by pressurised devices.
APPLICATIONS / PUFFIDO
P / 03Designed aroundpeople.
Asthma and COPD are the intended maintenance therapy applications. The platform addresses practical needs in administering inhaled medication.
ExploreFunctional prototype · Technology in development
01 / PEOPLE & PARTNERS
Every breath
has its value.
02 / APPLICATION
COPD
Pressure-assisted delivery, attentive to inhalation needs.
Mechanically assisted delivery is PuffIDO’s design principle. Performance and suitability for different populations require validation.
03 / APPLICATION
Pharmaceutical partners
Customised devices and refills through a B2B collaboration model.
The B2B model envisages pharmaceutical partnerships for customised devices and refills.
02 / NEXT HORIZON
One platform.
A broader horizon.
The roadmap includes an extension to liquid inhalers. A later development objective following the powder programme, rather than an already available feature.
The investor perspective
RESEARCH. INDUSTRY. NEW POSSIBILITIES.
The future is built
together.
Let’s open a conversation about the future of inhalation therapy.
Contact the team